INOVIO to Report First Quarter Financial Results on May 13, 2026
INOVIO (NASDAQ:INO) will release its first quarter 2026 financial results after market close on May 13, 2026.
Rhea-AI Summary
INOVIO (NASDAQ:INO) will release its first quarter 2026 financial results after market close on May 13, 2026. A live conference call and webcast will follow at 4:30 p.m. ET for a financial review and general business update, with a listen-only format and live Q&A.
The webcast will be archived and available for replay for 90 days at the company's investor events page.
Positive
- None.
Negative
- None.
Details
News Market Reaction – INO
On May 4, the first trading day after this news, INO closed 3.64% above the previous close.
Data tracked by StockTitan Argus for the May 4 session.
Key Figures
- Q1 2026 results date
- May 13, 2026
- Scheduled release after market close
- Conference call time
- 4:30 p.m. ET
- Start of earnings call and webcast
- Webcast replay period
- 90 days
- Archive duration for Q1 2026 webcast
Previous Earnings date Reports
-
Announced timing of Q4 and full-year 2025 results and related webcast.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event.
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing innovative DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com
Contacts
Media: Jennie Willson, (267) 429-8567, communications@inovio.com
Investors: Peter Vozzo - ICR Healthcare, (443) 213-0505, investor.relations@inovio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-report-first-quarter-financial-results-on-may-13-2026-302760436.html
SOURCE INOVIO Pharmaceuticals, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.